Our findings suggest the clinical utility of liquid biopsy in capturing tumor-derived genetic alterations and indicate that PIK3CA mutations are not uniformly distributed across subtypes, nor do they confer identical prognostic implications. Here, PIK3CA is linked to neoplasm.